cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc2841xd
title: CCDC 2089273: Experimental Crystal Structure Determination

description: Related Article: Ryan C. Cammarota, Wenbin Liu, John Bacsa, Huw M. L. Davies, Matthew S. Sigman|2022|J.Am.Chem.Soc.|144|1881|doi:10.1021/jacs.1c12198
DOI: 10.6084/m9.figshare.19144982
title: Supplementary Material for: Evolution of Quality of Life in Chronic Kidney Disease Stage 4–5 Patients Transitioning to Dialysis and Transplantation

description: <b><i>Introduction:</i></b> Chronic kidney disease (CKD) has a profound effect on patients’ health-related quality of life (QoL). Longitudinal studies on QoL in CKD are scarce and have explored selected patients on renal replacement therapy (RRT). We studied the evolution of QoL in patients with advanced CKD transitioning to dialysis and transplantation in a prospective follow-up study. <b><i>Methods:</i></b> A total of 100 participants of the Chronic Arterial Disease, Quality of Life, and Mortality in Chronic Kidney Injury (CADKID) study were enrolled in the study. Kidney Disease Quality of Life Short Form, biochemistry, and echocardiography were obtained at baseline and after a median interval of 33 (range 12–85) months. <b><i>Results:</i></b> At the time of the follow-up QoL assessment, 32 patients were not receiving RRT, 30 were on hemodialysis (HD), 19 on peritoneal dialysis (PD), and 19 had received a kidney transplant. Among kidney transplant recipients (KTRs), “Burden of Kidney Disease” and “General Health” domains improved compared to patients who initiated HD (<i>p</i> &lt; 0.0001 and <i>p</i> = 0.007, respectively), PD (<i>p</i> = 0.0005 and <i>p</i> = 0.03, respectively), or remained in predialysis care (<i>p</i> = 0.009 and <i>p</i> = 0.003, respectively) while “Effects of Kidney Disease” improved compared to those who started HD (<i>p</i> = 0.004) or PD (<i>p</i> = 0.002). The change in Short Form-36 (SF-36) Physical Component Summary was not different between patients on different treatment modalities. Higher plasma albumin and cholesterol levels were associated with improved QoL in “Symptoms/Problems” (<i>r</i> = 0.28, <i>p</i> = 0.005, and <i>r</i> = 0.30, <i>p</i> = 0.004, respectively) and “Effects of Kidney Disease” (<i>r</i> = 0.27, <i>p</i> = 0.008, and <i>r</i> = 0.24, <i>p</i> = 0.03, respectively). <b><i>Conclusion:</i></b> QoL improved in KTRs in kidney disease-specific domains compared to patients initiating dialysis or those without RRT. Plasma albumin and lipids were associated with QoL over time.
DOI: 10.48512/xcv8459952
title: 5MT10709 Map Log

description: 5MT10709 Map Log
DOI: 10.48512/xcv8459955
title: 5MT10718 Map Log

description: 5MT10718 Map Log
DOI: 10.5519/tb5zl1fq
title: Butler_Mambawakale

description: Pronunciation of Mambawakale ruhuhu gen. et sp. nov. by John Lyakurwa (University of Dar es Salaam, Tanzania)
DOI: 10.5255/ukda-sn-855432
title: Study to Explore Women's Childbirth Choices and Experiences, 2019-2020

description: Questionnaire data and interview transcripts with women who were currently pregnant or had recently given birth. Interview transcripts with maternity care professionals. Given the protocols used and inability to obtained retrospective consent the data cannot be shared.
DOI: 10.5281/zenodo.6021744
title: Test Dataset FFTLog.jl

description: Datasets containing some files to check the FFTLog.jl algorithm
DOI: 10.5281/zenodo.6021678
title: Test Dataset FFTLog.jl

description: Datasets containing some files to check the FFTLog.jl algorithm
DOI: 10.48512/xcv8459950
title: 5MT10686 Map Log

description: 5MT10686 Map Log
DOI: 10.6084/m9.figshare.14776239.v1
title: Untitled Item

description: Richness data for producing predict richness of Onygenales fungi globally.<br>
DOI: 10.6084/m9.figshare.14776239.v2
title: Humidity and low pH boost occurrence of Onygenales fungi in soil at global scale

description: Richness data for producing predict richness of Onygenales fungi globally.<br>
DOI: 10.6084/m9.figshare.14776239
title: Humidity and low pH boost occurrence of Onygenales fungi in soil at global scale

description: Richness data for producing predict richness of Onygenales fungi globally.<br>
DOI: 10.6084/m9.figshare.14776239.v3
title: Humidity and low pH boost occurrence of Onygenales fungi in soil at global scale

description: Richness data for producing predict richness of Onygenales fungi globally.<br>
DOI: 10.6084/m9.figshare.19144988
title: Full-length transcriptome reconstruction reveals the genetic mechanisms of eyestalk displacement and its potential implications on the novel interspecific hybrid crab (Scylla serrata ♀×Scylla paramamosain ♂)

description: The transcriptomes of normal eyestalk (SPA), interspecific hybrid crabs with normal eyestalk (NH), and interspecific hybrid crabs with displaced eyestalk (DH), and the novel interspecific hybrid crab were reconstructed using SMRT sequencing data with non-hybrid correction methods and two-step collapsing strategy.
DOI: 10.6084/m9.figshare.19144988.v1
title: Full-length transcriptome reconstruction reveals the genetic mechanisms of eyestalk displacement and its potential implications on the novel interspecific hybrid crab (Scylla serrata ♀×Scylla paramamosain ♂)

description: The transcriptomes of normal eyestalk (SPA), interspecific hybrid crabs with normal eyestalk (NH), and interspecific hybrid crabs with displaced eyestalk (DH), and the novel interspecific hybrid crab were reconstructed using SMRT sequencing data with non-hybrid correction methods and two-step collapsing strategy.
DOI: 10.5281/zenodo.6012046
title: Food fraud vulnerability assessment data (on spice/ginger and wine)

description: The dataset includes the results of food fraud vulnerability assessments (on spice/ginger and wine) of various companies based in China and Europe. The data form part of WP3 (Task 3.2): <em>Implementation of innovations in food authenticity. </em>The data is generated to better understand the food fraud vulnerability within selected food chains. The data is useful for anyone working in the field of food authentication.
DOI: 10.5281/zenodo.6012045
title: Food fraud vulnerability assessment data (on spice/ginger and wine)

description: The dataset includes the results of food fraud vulnerability assessments (on spice/ginger and wine) of various companies based in China and Europe. The data form part of WP3 (Task 3.2): <em>Implementation of innovations in food authenticity. </em>The data is generated to better understand the food fraud vulnerability within selected food chains. The data is useful for anyone working in the field of food authentication.
DOI: 10.5281/zenodo.6013260
title: Laboratory capability Survey - POPs in Food and Feed, CFSA

description: POPs analysis capabilities of China National Centre for Food Safety Risk Assessment (CSFA)
description: last updated: August 2019
DOI: 10.5281/zenodo.6013446
title: Laboratory capability Survey - POPs in Food and Feed, Hubei CDC

description: POPs analysis capability at the Hubei Centre for Disease Control (Hubei CDC), China
description: Last updated: August 2019
DOI: 10.5281/zenodo.6013259
title: Laboratory capability Survey - POPs in Food and Feed, CFSA

description: POPs analysis capabilities of China National Centre for Food Safety Risk Assessment (CSFA)
description: last updated: August 2019
DOI: 10.5281/zenodo.6013445
title: Laboratory capability Survey - POPs in Food and Feed, Hubei CDC

description: POPs analysis capability at the Hubei Centre for Disease Control (Hubei CDC), China
description: Last updated: August 2019
DOI: 10.5281/zenodo.6019357
title: Laboratory capability Survey - POPs in Food and Feed, VSCHT

description: POPs analysis capabilities at University of Chemistry and Technology (VSCHT), Prague, Czech Republic
description: Last Updated: August 2019
DOI: 10.5281/zenodo.6019533
title: Laboratory capability Survey - Pesticides, Fera

description: Pesticide analysis capabilities at Fera Science Ltd
description: Last updated: June 2019
DOI: 10.5281/zenodo.6019356
title: Laboratory capability Survey - POPs in Food and Feed, VSCHT

description: POPs analysis capabilities at University of Chemistry and Technology (VSCHT), Prague, Czech Republic
description: Last Updated: August 2019
DOI: 10.5281/zenodo.6019532
title: Laboratory capability Survey - Pesticides, Fera

description: Pesticide analysis capabilities at Fera Science Ltd
description: Last updated: June 2019
DOI: 10.5281/zenodo.6019786
title: Laboratory capability Survey - Pesticides, Teagasc

description: Pesticide analysis capabilities at Teagasc, Ireland
description: Last updated: August 2019
DOI: 10.5281/zenodo.6019944
title: Laboratory capability Survey - Pesticides, VSCHT

description: Pesticide analysis capabilities at University of Chemistry and Technology (VSCHT), Prague, Czech Republic
description: Last updated August 2019
DOI: 10.5281/zenodo.6019785
title: Laboratory capability Survey - Pesticides, Teagasc

description: Pesticide analysis capabilities at Teagasc, Ireland
description: Last updated: August 2019
DOI: 10.5281/zenodo.6019943
title: Laboratory capability Survey - Pesticides, VSCHT

description: Pesticide analysis capabilities at University of Chemistry and Technology (VSCHT), Prague, Czech Republic
description: Last updated August 2019
DOI: 10.5281/zenodo.4066235
title: The Variably Intense Vocalizations of Affect and Emotion Corpus (VIVAE)

description: <strong>VIVAE</strong> The Variably Intense Vocalizations of Affect and Emotion Corpus (VIVAE) consists of a set of human non-speech emotion vocalizations. The<em> full set,</em> comprising 1085 audio files, features eleven speakers expressing three positive (achievement/ triumph, sexual pleasure, and surprise) and three negative (anger, fear, physical pain) affective states, each parametrically varied from low to peak emotion intensity. The smaller <em>core set </em>of 480 files represents a fully crossed subsample of the full set (6 emotions x 4 intensities x 10 speakers x 2 items) selected based on judged authenticity. Please visit our academic paper for full details: <strong>Holz, N., Larrouy-Maestri, P., & Poeppel, D. (2022). The Variably Intense Vocalizations of Affect and Emotion (VIVAE) corpus prompts new perspective on nonspeech perception. <em>Emotion, 22</em>(1), 213–225. http://dx.doi.org/10.1037/emo0001048 </strong> <strong>File summary</strong> The recordings are digitized at a 44.1-kHz sampling rate and 16-bit resolution. Each of the 1085 VIVAE files has a unique filename following the file naming convention: [Speaker_Emotion_Intensity_Item-ID.wav]. The filename consists of a 4-part identifier (e.g., S04_surprise_peak_10.wav) defining the stimulus characteristics: <em>Filename identifiers </em> Speaker (S01 to S11). Emotion (achievement, anger, fear, pain, pleasure, and surprise). Emotional intensity (low, moderate, strong, peak). Item-ID (unique integer identifier within speaker x emotion x intensity conditions) <em>Folder structure</em> Full set: all 1085 VIVAE files Core set: selected 480 VIVAE files <strong>Citing the VIVAE</strong> Please cite the VIVAE if it is used in your work in any form. Academic works should use the citation for our academic paper. Holz, N., Larrouy-Maestri, P., & Poeppel, D. (2022). The Variably Intense Vocalizations of Affect and Emotion (VIVAE) corpus prompts new perspective on nonspeech perception. <em>Emotion, 22</em>(1), 213-225. http://dx.doi.org/10.1037/emo0001048<strong> </strong> <strong>License information</strong> The VIVAE is released under a Creative Commons Attribution-NonCommercial 4.0 International License, CC BY-NC 4.0. For VIVAE usage inquiries not specified or accredited under the CC BY-NC 4.0 license, please contact us at natalie.holz@ae.mpg.de to request permission.
DOI: 10.5281/zenodo.4066234
title: The Variably Intense Vocalizations of Affect and Emotion Corpus (VIVAE)

description: <strong>VIVAE</strong> The Variably Intense Vocalizations of Affect and Emotion Corpus (VIVAE) consists of a set of human non-speech emotion vocalizations. The<em> full set,</em> comprising 1085 audio files, features eleven speakers expressing three positive (achievement/ triumph, sexual pleasure, and surprise) and three negative (anger, fear, physical pain) affective states, each parametrically varied from low to peak emotion intensity. The smaller <em>core set </em>of 480 files represents a fully crossed subsample of the full set (6 emotions x 4 intensities x 10 speakers x 2 items) selected based on judged authenticity. Please visit our academic paper for full details: <strong>Holz, N., Larrouy-Maestri, P., & Poeppel, D. (2022). The Variably Intense Vocalizations of Affect and Emotion (VIVAE) corpus prompts new perspective on nonspeech perception. <em>Emotion, 22</em>(1), 213–225. http://dx.doi.org/10.1037/emo0001048 </strong> <strong>File summary</strong> The recordings are digitized at a 44.1-kHz sampling rate and 16-bit resolution. Each of the 1085 VIVAE files has a unique filename following the file naming convention: [Speaker_Emotion_Intensity_Item-ID.wav]. The filename consists of a 4-part identifier (e.g., S04_surprise_peak_10.wav) defining the stimulus characteristics: <em>Filename identifiers </em> Speaker (S01 to S11). Emotion (achievement, anger, fear, pain, pleasure, and surprise). Emotional intensity (low, moderate, strong, peak). Item-ID (unique integer identifier within speaker x emotion x intensity conditions) <em>Folder structure</em> Full set: all 1085 VIVAE files Core set: selected 480 VIVAE files <strong>Citing the VIVAE</strong> Please cite the VIVAE if it is used in your work in any form. Academic works should use the citation for our academic paper. Holz, N., Larrouy-Maestri, P., & Poeppel, D. (2022). The Variably Intense Vocalizations of Affect and Emotion (VIVAE) corpus prompts new perspective on nonspeech perception. <em>Emotion, 22</em>(1), 213-225. http://dx.doi.org/10.1037/emo0001048<strong> </strong> <strong>License information</strong> The VIVAE is released under a Creative Commons Attribution-NonCommercial 4.0 International License, CC BY-NC 4.0. For VIVAE usage inquiries not specified or accredited under the CC BY-NC 4.0 license, please contact us at natalie.holz@ae.mpg.de to request permission.
DOI: 10.17632/8kfgw8j8rn.1
title: Mangiameli et al., Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes. 

description: The dataset includes the row data of graphs shown in figures 1-6 of the paper: Mangiameli E, Cecchele A, Morena F, Sanvito F, Matafora V, Cattaneo A, Della Volpe L, Gnani D, Paulis M, Susani L, Martino S, Di Micco R, Bachi A, Gritti A. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes. Stem Cell Reports. 2021 Jun 8;16(6):1478-1495. doi: 10.1016/j.stemcr.2021.04.011. Epub 2021 May 13. PubMed PMID: 33989519; PubMed Central PMCID: PMC8190599.
The lipidomic dataset reported in the paper (Figure 7) is available at MetaboLights, accession number MTBLS1501 (https://www.ebi.ac.uk/metabolights/MTBLS1501).

Globoid cell leukodystrophy (GLD) is a rare neurodegenerative lysosomal storage disease caused by an inherited deficiency of β-galactocerebrosidase (GALC). GLD pathogenesis and therapeutic correction have been poorly studied in patient neural cells. Here, we investigated the impact of GALC deficiency and lentiviral vector-mediated GALC rescue/overexpression in induced pluripotent stem cell (iPSC)-derived neural progenitors and neuronal/glial progeny obtained from two GLD patients. GLD neural progeny displayed progressive psychosine storage, oligodendroglial and neuronal defects, unbalanced lipid composition, and early activation of cellular senescence, depending on the disease-causing mutation. The partial rescue of the neural differentiation program upon GALC reconstitution and psychosine clearance suggests multiple mechanisms contributing to neural pathology in GLD. Also, the pathological phenotype associated to supraphysiological GALC levels highlights the need of regulated GALC expression for proper human neural commitment/differentiation. These data have important implications for establishing safe therapeutic strategies to enhance disease correction of GLD.
DOI: 10.48370/ofd/70bqlb
title: Calocera viscosa (Pers.: Fr.) Fr., 126

description: Fungarium Macromycetes
DOI: 10.5281/zenodo.6021713
title: Adriatic Sea wind-wave climate years 1981-2010 and 2021-2050 (RCP4.5 and RCP8.5)

description: Adriatic Sea mean annual 50th, 90th, 95th and 99th percentiles of the significant wave height (Hs) from WAVEWATCH III v6.07 (2 km) forced with 1-hour ERA5 wind fields statistically scaled to QQ-match COSMO-CLM fields (available at https://doi.org/10.5281/zenodo.6021380). Reference periods: 1) Historical climate: years 1981-2010 2) Future climate: years 2021-2050 (IPCC scenario RCP4.5 and RCP8.5)
DOI: 10.5281/zenodo.6021712
title: Adriatic Sea wind-wave climate years 1981-2010 and 2021-2050 (RCP4.5 and RCP8.5)

description: Adriatic Sea mean annual 50th, 90th, 95th and 99th percentiles of the significant wave height (Hs) from WAVEWATCH III v6.07 (2 km) forced with 1-hour ERA5 wind fields statistically scaled to QQ-match COSMO-CLM fields (available at https://doi.org/10.5281/zenodo.6021380). Reference periods: 1) Historical climate: years 1981-2010 2) Future climate: years 2021-2050 (IPCC scenario RCP4.5 and RCP8.5)
DOI: 10.6084/m9.figshare.19145054.v1
title: Untitled Item

description: the file contains for each specimen the raw data of the biomechanical parameters studied in the paper.<br>
DOI: 10.5281/zenodo.6022225
title: Test

description: Test anonymous
DOI: 10.5281/zenodo.6022224
title: Test

description: Test anonymous
DOI: 10.6084/m9.figshare.13655975.v8
title: Characteristics of volunteers

description: Description of the volunteers including age, sex, height and others anthropometric data.<br>
DOI: 10.6084/m9.figshare.19145072
title: Supplementary Material for: The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study

description: <b><i>Introduction:</i></b> Currently, the effect of hemoperfusion on outcome in severe COVID-19 patients is still unknown. Therefore, we aimed to investigate the effects of early HA-330 hemoperfusion in severe COVID-19 patients. <b><i>Methods:</i></b> We conducted a single center, prospective cohort study on patients who were diagnosed with severe COVID-19 patients and admitted to ICU. Patients in hemoperfusion group (defined as patients who were treated with hemoperfusion therapy at least 3 sessions in combination with standard therapy) were compared with the control group (defined as patients who received standard treatment alone or received less than 3 sessions of hemoperfusion therapy). The primary outcome was daily sequential organ failure assessment (SOFA) scores. Secondary outcomes were all-cause mortality at 28 days, mechanical ventilator-free day, daily C-reactive protein (CRP), oxygenation (defined by PaO<sub>2</sub>/FiO<sub>2</sub> ratio), and severity score of lung infiltration on the chest X-ray (CXR RALE score). All outcomes were adjusted by regression analysis to reduce the confounders due to some difference in baseline characteristics. <b><i>Results:</i></b> A total number of 29 severe and critical COVID-19 confirmed patients were enrolled. Fifteen patients were defined as hemoperfusion group and 14 were control group. The median of CRP and SOFA score at the baseline (the day after severe pneumonia diagnosis or before hemoperfusion) in hemoperfusion and control groups were comparable, 96.79 mg/L and 87.3 mg/L, <i>p</i> = 0.53, 3.53 ± 0.99 versus 4.3 ± 1.89, <i>p</i> = 0.15, respectively. Clinical improvement associated with decreased SOFA score and improvement of CXR RALE score were found in hemoperfusion group compared to control group (<i>p</i> = 0.008 and <i>p</i> = 0.005, respectively). The 28-day mortality rate was significantly lower in hemoperfusion group compared to control group (6.67% vs. 85.71%, <i>p</i> &lt; 0.001) and the adjusted hazard ratio of death was 0.017 (95% confidence interval = 0.008–0.351, <i>p</i> = 0.008). <b><i>Conclusions:</i></b> The addition of early HA-330 hemoperfusion to standard therapy improved severity of organ failure and might reduce the mortality rate. However, the results were affected by the baseline confounders and limited sample size.
DOI: 10.6084/m9.figshare.19145054.v2
title: Results data

description: the file contains for each specimen the raw data of the biomechanical parameters studied in the paper.<br>
DOI: 10.6084/m9.figshare.17696831
title: Data for Wyka et al. Anatomical adjustment of mature leaves

description: Data are organized into four groups of variables: 1) anatomy, 2) LMA, pigments and nitrogen, 3) chlorophyll fluorescence, 4) leaf abscission, each in a separate sheet. Treatment abbreviations: PRE – measurements taken prior to transfer to full sun; CONT – measurements on plants remaining at original growth irradiances, TRANS – measurements on plants that had been transferred to full sun.<br><b>Correction Feb. 09, 2022:</b> It has been brought to our attention that chlorophyll a/b ratios and pigment concentrations in this data set were unrealistically high. We agree with this opinion based on literature review and attribute these erroneous results to a laboratory mistake. Since measurements cannot be repeated we have deleted the data. We have also contacted Photosynthesis Research editor about this issue. The remaining data are sound.<br>
DOI: 10.6084/m9.figshare.17696831.v2
title: Data for Wyka et al. Anatomical adjustment of mature leaves

description: Data are organized into four groups of variables: 1) anatomy, 2) LMA, pigments and nitrogen, 3) chlorophyll fluorescence, 4) leaf abscission, each in a separate sheet. Treatment abbreviations: PRE – measurements taken prior to transfer to full sun; CONT – measurements on plants remaining at original growth irradiances, TRANS – measurements on plants that had been transferred to full sun.<br><b>Correction Feb. 09, 2022:</b> It has been brought to our attention that chlorophyll a/b ratios and pigment concentrations in this data set were unrealistically high. We agree with this opinion based on literature review and attribute these erroneous results to a laboratory mistake. Since measurements cannot be repeated we have deleted the data. We have also contacted Photosynthesis Research editor about this issue. The remaining data are sound.<br>
DOI: 10.6084/m9.figshare.17696831.v1
title: Data for Wyka et al. Anatomical adjustment of mature leaves

description: Data are organized into four groups of variables: 1) anatomy, 2) LMA, pigments and nitrogen, 3) chlorophyll fluorescence, 4) leaf abscission, each in a separate sheet. Treatment abbreviations: PRE – measurements taken prior to transfer to full sun; CONT – measurements on plants remaining at original growth irradiances, TRANS – measurements on plants that had been transferred to full sun.
DOI: 10.5517/ccdc.csd.cc28bsv8
title: CCDC 2095750: Experimental Crystal Structure Determination

description: Related Article: Ryan C. Cammarota, Wenbin Liu, John Bacsa, Huw M. L. Davies, Matthew S. Sigman|2022|J.Am.Chem.Soc.|144|1881|doi:10.1021/jacs.1c12198
DOI: 10.5517/ccdc.csd.cc285s7h
title: CCDC 2090926: Experimental Crystal Structure Determination

description: Related Article: Ryan C. Cammarota, Wenbin Liu, John Bacsa, Huw M. L. Davies, Matthew S. Sigman|2022|J.Am.Chem.Soc.|144|1881|doi:10.1021/jacs.1c12198
DOI: 10.5517/ccdc.csd.cc28js4r
title: CCDC 2101494: Experimental Crystal Structure Determination

description: Related Article: Kyle D. Spielvogel, Nathan C. Stumme, Taylor V. Fetrow, Li Wang, Javier A. Luna, Jason M. Keith, Scott K. Shaw, Scott R. Daly|2022|Inorg.Chem.|61|2391|doi:10.1021/acs.inorgchem.1c03014
DOI: 10.5517/ccdc.csd.cc28js5s
title: CCDC 2101495: Experimental Crystal Structure Determination

description: Related Article: Kyle D. Spielvogel, Nathan C. Stumme, Taylor V. Fetrow, Li Wang, Javier A. Luna, Jason M. Keith, Scott K. Shaw, Scott R. Daly|2022|Inorg.Chem.|61|2391|doi:10.1021/acs.inorgchem.1c03014